OBJECTIVES: We investigated whether the prevalence of contraceptive use among women who are HIV positive varied according to use of highly active antiretroviral therapy (HAART) in Mbarara, Uganda. METHODS: We used data from a cross-sectional survey of 484 women who were HIV positive (18-50 years) and were attending Mbarara University's HIV clinic, 45% of whom were receiving HAART. Multivariate logistic regression was used to investigate the association between HAART use and contraceptive use. Data were collected between November 2005 and June 2006. RESULTS: Overall, 45% of the women were sexually active in the previous 3 months. Of these, 85% reported using contraceptive methods, with 84% reporting use of barrier contraceptive methods. Women receiving HAART were more than twice as likely to use contraceptive methods (adjusted odds ratio [AOR] = 2.64; 95% confidence interval [CI] = 1.07, 6.49) and more than 3 times as likely to use barrier contraceptive methods (AOR = 3.62; 95% CI = 1.54, 8.55) than were women not receiving HAART. CONCLUSIONS: Our findings support the need for increased attention to better integration of reproductive health and HIV and AIDS services for women who are HIV positive.
OBJECTIVES: We investigated whether the prevalence of contraceptive use among women who are HIV positive varied according to use of highly active antiretroviral therapy (HAART) in Mbarara, Uganda. METHODS: We used data from a cross-sectional survey of 484 women who were HIV positive (18-50 years) and were attending Mbarara University's HIV clinic, 45% of whom were receiving HAART. Multivariate logistic regression was used to investigate the association between HAART use and contraceptive use. Data were collected between November 2005 and June 2006. RESULTS: Overall, 45% of the women were sexually active in the previous 3 months. Of these, 85% reported using contraceptive methods, with 84% reporting use of barrier contraceptive methods. Women receiving HAART were more than twice as likely to use contraceptive methods (adjusted odds ratio [AOR] = 2.64; 95% confidence interval [CI] = 1.07, 6.49) and more than 3 times as likely to use barrier contraceptive methods (AOR = 3.62; 95% CI = 1.54, 8.55) than were women not receiving HAART. CONCLUSIONS: Our findings support the need for increased attention to better integration of reproductive health and HIV and AIDS services for women who are HIV positive.
Authors: Marissa Maier; Irene Andia; Nneka Emenyonu; David Guzman; Angela Kaida; Larry Pepper; Robert Hogg; David R Bangsberg Journal: AIDS Behav Date: 2008-04-04
Authors: R H Gray; M J Wawer; D Serwadda; N Sewankambo; C Li; F Wabwire-Mangen; L Paxton; N Kiwanuka; G Kigozi; J Konde-Lule; T C Quinn; C A Gaydos; D McNairn Journal: Lancet Date: 1998-01-10 Impact factor: 79.321
Authors: Catherine S Todd; Tracy C Anderman; Sarah Long; Landon Myer; Linda-Gail Bekker; Gregory A Petro; Heidi E Jones Journal: Contraception Date: 2018-02-09 Impact factor: 3.375
Authors: Kartik K Venkatesh; A K Srikrishnan; Steven A Safren; Elizabeth W Triche; E Thamburaj; Lakshmi Prasad; Mark N Lurie; M Suresh Kumar; N Kumarasamy; Suniti Solomon; Kenneth H Mayer Journal: AIDS Care Date: 2011-06
Authors: Christina I Nieves; Angela Kaida; George R Seage; Jerome Kabakyenga; Winnie Muyindike; Yap Boum; A Rain Mocello; Jeffrey N Martin; Peter W Hunt; Jessica E Haberer; David R Bangsberg; Lynn T Matthews Journal: Contraception Date: 2015-05-14 Impact factor: 3.375
Authors: John S Santelli; Zoe R Edelstein; Sanyukta Mathur; Ying Wei; Wenfei Zhang; Mark G Orr; Jenny A Higgins; Fred Nalugoda; Ron H Gray; Maria J Wawer; David M Serwadda Journal: J Acquir Immune Defic Syndr Date: 2013-07-01 Impact factor: 3.731
Authors: Angela Kaida; Viviane Dias Lima; Irene Andia; Jerome Kabakyenga; Pamela Mbabazi; Nneka Emenyonu; Thomas L Patterson; Robert S Hogg; David R Bangsberg Journal: AIDS Behav Date: 2009-04-22
Authors: Lynn T Matthews; Angela Kaida; Steven Kanters; Helen Byakwagamd; A Rain Mocello; Conrad Muzoora; Annet Kembabazi; Jessica E Haberer; Jeffrey N Martin; David R Bangsberg; Peter W Hunt Journal: AIDS Date: 2013-10 Impact factor: 4.177